Immunogenic Response to COVID-19 Vaccination in Diabetic Populations

Summary

Individuals with diabetes mellitus exhibit distinct challenges in mounting and maintaining protective immunity following COVID-19 vaccination. Hyperglycaemia and associated metabolic disturbances impair antigen presentation, T-cell activation and B-cell maturation, leading to lower peak antibody titres and diminished cellular responses when compared with non-diabetic peers. Glycaemic control emerges as a key determinant of vaccine efficacy, influencing both humoral neutralising capacity and T-helper 1 cytokine responses. Diabetic subgroups, particularly those with poor long-term glucose regulation or high body mass index, frequently display a more rapid decline in vaccine-induced immunity and an increased incidence of breakthrough infections. Understanding the interplay between metabolic status, vaccine platform and immune kinetics is essential for optimising booster schedules, refining public-health prioritisation and guiding personalised vaccination strategies in this vulnerable population.

Research from Nature Portfolio

A prospective study in adults with type 2 diabetes who received an mRNA-BNT162b2 vaccination series revealed that mean glycated haemoglobin (HbA1c) levels during the post-vaccination year strongly correlated with both virus-neutralising antibody capacity and CD4+ T-cell cytokine output. Participants with sustained HbA1c below 7% maintained higher neutralising titres and a more robust T-helper 1 profile over twelve months, whereas those with HbA1c ≥ 7% exhibited a linear increase in breakthrough infections. Multivariate analysis further identified poor glycaemic control as an independent predictor of reduced immune durability and heightened infection risk despite full vaccination.

Immunogenic Response to COVID-19 Vaccination in Diabetic Populations publication trend

The graph below shows the total number of articles in immunogenic response to covid-19 vaccination in diabetic populations across all publications each year (not limited to Nature Index journals).

Technical terms

Neutralising antibody capacity: The functional ability of serum antibodies to prevent viral entry into host cells.

CD4+ T-helper 1 (Th1) cells: A subset of T lymphocytes that secrete cytokines to support cellular immunity against intracellular pathogens.

Glycaemic control (HbA1c): A measure of average blood glucose concentration over the preceding two to three months.

Memory B cells: Long-lived B lymphocytes that rapidly differentiate into antibody-secreting cells upon antigen re-exposure.

References

  1. Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes. Nature Communications (2022).
  2. Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review. Frontiers in Immunology (2022).
  3. Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study. Vaccines (2022).
  4. Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines. Frontiers in Immunology (2022).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.